Jul 2026
Abstract B094: Suppressing ERG-driven oncogenesis by mRNA-based delivery of an intracellular mini-body targeting a unique protein methylation site in ERG fusion-positive prostate cancer
The feasibility and efficacy of this novel mini-body-based strategy as a viable therapeutic modality for targeting an oncogenic transcription factor previously considered undruggable are established and supports further translational development for targeting ERG-driven prostate cancer.
C. Musumeci, Concetta Guerra, D. Albino et al.
· Clinical Cancer Research · 0 citations